Home » Headlines » Currently Reading:

Morning Headlines 1/24/20

January 23, 2020 Headlines 2 Comments

23andMe lays off 100 people as DNA test sales decline, CEO says she was ‘surprised’ to see market turn

Consumer DNA testing company 23andMe lays off 100 employees as it struggles with declining sales.

Babylon Health is building an integrated, AI-based health app to serve a city of 300K in England

Babylon Health signs a 10-year agreement with the Royal Wolverhampton NHS Trust to develop an app that will offer the city’s residents diagnoses, virtual care, and monitoring of chronic conditions; plus appointment booking, prescription refills, and other care management capabilities.

Wuhan Coronavirus: Epic Sends Automatic Travel Screening Update to Spot New Cases

Epic updates its software to include travel screening prompts for patients who may have traveled from China or who are experiencing symptoms of the coronavirus.

Cybersecurity Vulnerabilities in Certain GE Healthcare Clinical Information Central Stations and Telemetry Servers: Safety Communication

The FDA alerts hospitals to cybersecurity flaws found in some GE Healthcare Clinical Information Central Stations and Telemetry Servers that could enable hackers to effectively take over devices and gain access to PHI.



HIStalk Featured Sponsors

     

Currently there are "2 comments" on this Article:

  1. 23andMe CEO is surprised that nobody wants to give their DNA to a company that just announced its been using it to develop new medications and selling the rights to a Spanish pharmaceutical company.

    Gosh, that’s a weird and totally unexpected consumer response, who would have seen that coming.

    • That’s probably true but it could just be a matter of market saturation. How many people are left who want to use the service but haven’t? Its been around for a while and I can’t imagine the type of consumer willing to drop a hundred bucks on genetic testing is the same type to wait for years to decide. It’s not like this is a product a consumer will repeatedly buy either. Frankly, isn’t it obvious that this kind of product would have limited market viability? I’m surprised the CEO is surprised.







Text Ads


RECENT COMMENTS

  1. I think Disingenuous is confused (or simply not aware of how it has been architected). How control of Epic is…

  2. It seems that every innovation in the past 50 years has claimed that it would save money and lives. There…

  3. Well, this is predicting the future, and my crystal ball is cloudy and cracked. But my basic thesis about Meditech?…

  4. RE Judy Faulkner's foundation wishes: Different area, but read up on the Barnes Foundation to see how things work out…

  5. Meditech certainly benefited from Cerner and Allscripts stumbles and before that the failures of ECW and Athena’s inpatient expansions. I…

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

RSS Webinars

  • An error has occurred, which probably means the feed is down. Try again later.